Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Gualano B, DE Salles Painneli V, Roschel H, Artioli GG, Neves M Jr, De Sá Pinto AL, Da Silva ME, Cunha MR, Otaduy MC, Leite Cda C, Ferreira JC, Pereira RM, Brum PC, Bonfá E, Lancha AH Jr. Gualano B, et al. Among authors: cunha mr. Med Sci Sports Exerc. 2011 May;43(5):770-8. doi: 10.1249/MSS.0b013e3181fcee7d. Med Sci Sports Exerc. 2011. PMID: 20881878 Clinical Trial.
Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial.
Gualano B, de Salles Painelli V, Roschel H, Lugaresi R, Dorea E, Artioli GG, Lima FR, da Silva ME, Cunha MR, Seguro AC, Shimizu MH, Otaduy MC, Sapienza MT, da Costa Leite C, Bonfá E, Lancha Junior AH. Gualano B, et al. Among authors: cunha mr. Eur J Appl Physiol. 2011 May;111(5):749-56. doi: 10.1007/s00421-010-1676-3. Epub 2010 Oct 26. Eur J Appl Physiol. 2011. PMID: 20976468 Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against Mycobacterium abscessus and Mycobacterium avium, Two Emerging Human Pathogens.
Andrade Meirelles M, Almeida VM, Sullivan JR, de Toledo I, Dos Reis CV, Cunha MR, Zigweid R, Shim A, Sankaran B, Woodward EL, Seibold S, Liu L, Mian MR, Battaile KP, Riley J, Duncan C, Simeons FRC, Ferguson L, Joji H, Read KD, Lovell S, Staker BL, Behr MA, Pilli RA, Couñago RM. Andrade Meirelles M, et al. Among authors: cunha mr. J Med Chem. 2024 Oct 28. doi: 10.1021/acs.jmedchem.4c01594. Online ahead of print. J Med Chem. 2024. PMID: 39468773
Transcriptional regulators of fetal hemoglobin.
Santos GPD, Rabi LT, Bezerra AA, da Cunha MR, Iatecola A, Fernandes VAR. Santos GPD, et al. Among authors: da cunha mr. Hematol Transfus Cell Ther. 2024 Aug 17:S2531-1379(24)00296-7. doi: 10.1016/j.htct.2024.06.001. Online ahead of print. Hematol Transfus Cell Ther. 2024. PMID: 39237431 Free article. Review.
European Study of Cerebral Aspergillosis treated with Isavuconazole (ESCAI): A study by the ESCMID Fungal Infection Study Group.
Serris A, Rautemaa-Richardson R, Laranjinha JD, Candoni A, Garcia-Vidal C, Alastruey-Izquierdo A, Hammarström H, Seidel D, Styczynski J, Sabino R, Lamoth F, Prattes J, Warris A, Porcher R, Lanternier F; ESCAI Study Group. Serris A, et al. Clin Infect Dis. 2024 Oct 15;79(4):936-943. doi: 10.1093/cid/ciae371. Clin Infect Dis. 2024. PMID: 39076104
(S)-ML-SA1 Activates Autophagy via TRPML1-TFEB Pathway.
Cunha MR, Do Amaral BS, Takarada JE, Valderrama GV, Batista ANL, Batista JM Jr, Cass QB, Couñago RM, Massirer KB. Cunha MR, et al. Chembiochem. 2024 Jun 25:e202400506. doi: 10.1002/cbic.202400506. Online ahead of print. Chembiochem. 2024. PMID: 38923811
Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε.
de Souza Gama FH, Dutra LA, Hawgood M, Dos Reis CV, Serafim RAM, Ferreira MA Jr, Teodoro BVM, Takarada JE, Santiago AS, Balourdas DI, Nilsson AS, Urien B, Almeida VM, Gileadi C, Ramos PZ, Salmazo A, Vasconcelos SNS, Cunha MR, Mueller S, Knapp S, Massirer KB, Elkins JM, Gileadi O, Mascarello A, Lemmens BBLG, Guimarães CRW, Azevedo H, Couñago RM. de Souza Gama FH, et al. Among authors: cunha mr. J Med Chem. 2024 Jun 13;67(11):8609-8629. doi: 10.1021/acs.jmedchem.3c02250. Epub 2024 May 23. J Med Chem. 2024. PMID: 38780468
127 results